ROVESTI, GIULIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.011
AS - Asia 1.397
EU - Europa 1.333
SA - Sud America 201
Continente sconosciuto - Info sul continente non disponibili 53
AF - Africa 43
OC - Oceania 17
Totale 6.055
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.907
IT - Italia 546
SG - Singapore 413
CN - Cina 350
VN - Vietnam 196
GB - Regno Unito 189
BR - Brasile 148
HK - Hong Kong 147
DE - Germania 108
SE - Svezia 92
FI - Finlandia 70
BD - Bangladesh 65
RU - Federazione Russa 65
FR - Francia 57
CA - Canada 53
IE - Irlanda 48
ID - Indonesia 36
KR - Corea 36
IN - India 29
JP - Giappone 25
NL - Olanda 24
TR - Turchia 22
MX - Messico 21
BE - Belgio 20
AR - Argentina 19
UA - Ucraina 18
AL - Albania 16
AU - Australia 16
IQ - Iraq 16
BG - Bulgaria 15
ES - Italia 14
PK - Pakistan 11
ZA - Sudafrica 11
AT - Austria 10
CO - Colombia 10
PL - Polonia 8
CZ - Repubblica Ceca 7
MY - Malesia 7
AE - Emirati Arabi Uniti 6
CL - Cile 6
EC - Ecuador 6
CR - Costa Rica 5
JM - Giamaica 5
KE - Kenya 5
LT - Lituania 5
MA - Marocco 5
AZ - Azerbaigian 4
EG - Egitto 4
NG - Nigeria 4
NI - Nicaragua 4
NP - Nepal 4
TN - Tunisia 4
VE - Venezuela 4
BO - Bolivia 3
BY - Bielorussia 3
BZ - Belize 3
CH - Svizzera 3
IR - Iran 3
OM - Oman 3
PE - Perù 3
RO - Romania 3
RS - Serbia 3
SA - Arabia Saudita 3
SI - Slovenia 3
SV - El Salvador 3
TW - Taiwan 3
UZ - Uzbekistan 3
BW - Botswana 2
DZ - Algeria 2
GE - Georgia 2
GP - Guadalupe 2
KZ - Kazakistan 2
PA - Panama 2
PH - Filippine 2
PT - Portogallo 2
TH - Thailandia 2
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
CI - Costa d'Avorio 1
CM - Camerun 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
EU - Europa 1
GH - Ghana 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
JO - Giordania 1
LK - Sri Lanka 1
MD - Moldavia 1
ML - Mali 1
MN - Mongolia 1
MQ - Martinica 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
Totale 6.000
Salva come PNG Salva come JPEG
Città #
Ashburn 339
Singapore 283
Santa Clara 268
San Jose 198
Fairfield 185
Chandler 145
Council Bluffs 139
Hong Kong 134
Houston 91
Sunnyvale 89
Modena 85
Hefei 77
Wilmington 77
Southend 75
Seattle 73
Woodbridge 72
New York 68
Beijing 65
Nyköping 65
Bologna 63
Cambridge 60
Los Angeles 60
Ann Arbor 59
Helsinki 58
London 57
Ho Chi Minh City 51
Dublin 46
Hanoi 44
The Dalles 41
Milan 40
Munich 34
Seoul 34
Dallas 31
Jakarta 30
Dearborn 29
Chicago 28
Jacksonville 24
Orem 23
San Diego 23
Toronto 21
Boardman 20
Buffalo 19
Reggio Emilia 19
Bremen 16
Brussels 16
Fremont 16
Shanghai 16
Princeton 15
Sofia 15
Florence 14
Lauterbourg 14
Moscow 14
Da Nang 13
Frankfurt am Main 13
Atlanta 12
Brooklyn 12
Phoenix 12
São Paulo 12
Tirana 12
Guangzhou 11
San Giuliano Milanese 11
Tokyo 11
Dong Ket 10
Montreal 10
Rome 10
Turku 10
Denver 9
Haiphong 9
Hangzhou 9
Mumbai 9
Adelaide 8
Chennai 8
Columbus 8
Eugene 8
Falls Church 8
Mexico City 8
Parma 8
Amsterdam 7
Izmir 7
Naples 7
Redondo Beach 7
Salt Lake City 7
Shinjuku 7
Genoa 6
Johannesburg 6
Manchester 6
Nuremberg 6
Redwood City 6
Rio de Janeiro 6
Vienna 6
Warsaw 6
Aydin 5
Can Tho 5
Fidenza 5
Grimes 5
Ottawa 5
Padova 5
Paris 5
San Francisco 5
Stockholm 5
Totale 3.964
Salva come PNG Salva come JPEG
Nome #
Soluble TRAIL Armed Human MSC As Gene Therapy For Pancreatic Cancer 447
Inducible Caspase9-mediated suicide gene for MSC-based cancer gene therapy 441
MSC-delivered soluble TRAIl and paclitaxel as novel combinatory treatment for pancreatic adenocarcinoma 437
SOLUBLE TRAIL-ARMED HUMAN AD-MSC AS NOVEL CELL THERAPY APPROACH FOR PANCREATIC DUCTAL ADENOCARCINOMA 401
Management of adverse events with tailored sorafenib dosing prolongs survival of hepatocellular carcinoma patients 398
Axillary Ectopic Carcinoma of the Breast. Report of Two Cases with Different Clinical Presentation and Review of the Literature. 383
1H-NMR based serum metabolomics highlights different specific biomarkers between early and advanced hepatocellular carcinoma stages 298
ANGPT2 and NOS3 Polymorphisms and Clinical Outcome in Advanced Hepatocellular Carcinoma Patients Receiving Sorafenib 292
Autologous anti-GD2 CAR T cells efficiently target primary human glioblastoma 281
Immunotherapy: ANTI-GD2 CAR T CELLS AGAINST SMALL CELL LUNG CANCER 266
TRAIL receptors are expressed in both malignant and stromal cells in pancreatic ductal adenocarcinoma 259
Clinical implications of malnutrition in the management of patients with pancreatic cancer: Introducing the concept of the nutritional oncology board 254
The growing skyline of advanced hepatocellular carcinoma treatment: A review. 244
Immunotherapy: AUTOLOGOUS ANTI-GD2 CAR T CELLS EFFICIENTLY TARGET PRIMARY HUMAN GLIOBLASTOMA 226
Chapter 8 - Hybrid polymeric scaffolds for brain applications: locoregional glioblastoma therapy 203
Impact of Baseline Characteristics on the Overall Survival of HCC Patients Treated with Sorafenib: Ten Years of Experience 178
Could inflammatory indices and metabolic syndrome predict the risk of cancer development? Analysis from the bagnacavallo population study 173
Prognostic Role of a New Index (RAPID Index) in Advanced Hepatocellular Carcinoma Patients Receiving Sorafenib: Training and Validation Cohort 170
BRCA in Gastrointestinal Cancers: Current Treatments and Future Perspectives 167
Utility of neutrophil-to-lymphocyte ratio to identify long-term survivors among HCC patients treated with sorafenib 162
Retrospective survival analysis in patients with metastatic pancreatic ductal adenocarcinoma with insulin-treated type 2 diabetes mellitus 158
External validation of surrogate indices of fatty liver in the general population: The Bagnacavallo study 145
CAR-T for Lung Cancers: Challenges and Innovations 72
Totale 6.055
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.730
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.730
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022313 0 0 0 8 26 54 28 25 26 34 81 31
2022/2023494 63 56 28 46 48 48 9 51 85 7 27 26
2023/2024267 8 12 18 28 33 40 9 27 9 17 22 44
2024/20251.291 24 24 61 121 206 212 115 78 151 73 98 128
2025/20262.097 165 64 115 239 285 124 290 105 226 253 164 67
2026/2027605 50 223 153 179 0 0 0 0 0 0 0 0
Totale 6.055